Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

NCT02673021 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02673021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
June 8, 2016
Completion date
March 13, 2020
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lung, cancer of the lung, lung cancer, lung neoplasms, metastatic cancer to the lung, neoplasms, lung, neoplasms, pulmonary, pulmonary cancer, pulmonary neoplasms